| Ovarian cancer: identifying and managing familial and genetic risk | NG241 | | |
| Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management | NG240 | | |
| Neonatal infection: antibiotics for prevention and treatment | NG195 | | |
| Lung cancer: diagnosis and management | NG122 | | |
| Vitamin B12 deficiency in over 16s: diagnosis and management | NG239 | | |
| Tuberculosis | NG33 | | |
| Sebelipase alfa for treating Wolman disease | HST30 | | |
| Cardiovascular disease: risk assessment and reduction, including lipid modification | NG238 | | |
| Velmanase alfa for treating alpha-mannosidosis | HST29 | | |
| Acne vulgaris: management | NG198 | | |
| Transient loss of consciousness ('blackouts') in over 16s | CG109 | | |
| Hypertension in adults: diagnosis and management | NG136 | | |
| Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer | CG164 | | |
| Jaundice in newborn babies under 28 days | CG98 | | |
| Stroke rehabilitation in adults | NG236 | | |
| Thyroid disease: assessment and management | NG145 | | |
| Ovarian cancer: recognition and initial management | CG122 | | |
| Urinary incontinence in neurological disease: assessment and management | CG148 | | |
| Suspected neurological conditions: recognition and referral | NG127 | | |
| Hearing loss in adults: assessment and management | NG98 | | |
| Birch bark extract for treating epidermolysis bullosa | HST28 | | |
| Cirrhosis in over 16s: assessment and management | NG50 | | |
| Spinal metastases and metastatic spinal cord compression | NG234 | | |
| Otitis media with effusion in under 12s | NG233 | | |
| Ectopic pregnancy and miscarriage: diagnosis and initial management | NG126 | | |
| Venous thromboembolic diseases: diagnosis, management and thrombophilia testing | NG158 | | |
| Afamelanotide for treating erythropoietic protoporphyria | HST27 | | |
| Oesophago-gastric cancer: assessment and management in adults | NG83 | | |
| Head injury: assessment and early management | NG232 | | |
| Diabetes (type 1 and type 2) in children and young people: diagnosis and management | NG18 | | |
| Metastatic malignant disease of unknown primary origin in adults: diagnosis and management | CG104 | | |
| Lumasiran for treating primary hyperoxaluria type 1 | HST25 | | |
| Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency | HST26 | | |
| Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy | HST24 | | |
| Onasemnogene abeparvovec for treating spinal muscular atrophy | HST15 | | |
| Hypertension in pregnancy: diagnosis and management | NG133 | | |
| Asfotase alfa for treating paediatric-onset hypophosphatasia | HST23 | | |
| Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene | HST22 | | |
| Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management | NG231 | | |
| Delirium: prevention, diagnosis and management in hospital and long-term care | CG103 | | |
| Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education | NG213 | | |
| Hip fracture: management | CG124 | | |
| Thyroid cancer: assessment and management | NG230 | | |
| Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management | NG228 | | |
| Fractures (complex): assessment and management | NG37 | | |
| Advocacy services for adults with health and social care needs | NG227 | | |
| Osteoarthritis in over 16s: diagnosis and management | NG226 | | |
| Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas | CG118 | | |
| Self-harm: assessment, management and preventing recurrence | NG225 | | |
| Type 1 diabetes in adults: diagnosis and management | NG17 | | |
| Melanoma: assessment and management | NG14 | | |
| Urinary tract infection in under 16s: diagnosis and management | NG224 | | |
| Setmelanotide for treating obesity caused by LEPR or POMC deficiency | HST21 | | |
| Social, emotional and mental wellbeing in primary and secondary education | NG223 | | |
| Type 2 diabetes in adults: management | NG28 | | |
| Depression in adults: treatment and management | NG222 | | |
| Multiple sclerosis in adults: management | NG220 | | |
| Reducing sexually transmitted infections | NG221 | | |
| Preterm labour and birth | NG25 | | |
| Gout: diagnosis and management | NG219 | | |
| Social work with adults experiencing complex needs | NG216 | | |
| Vaccine uptake in the general population | NG218 | | |
| Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over | HST20 | | |
| Elosulfase alfa for treating mucopolysaccharidosis type 4A | HST19 | | |
| Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults | NG215 | | |
| Stroke and transient ischaemic attack in over 16s: diagnosis and initial management | NG128 | | |
| Atidarsagene autotemcel for treating metachromatic leukodystrophy | HST18 | | |
| Integrated health and social care for people experiencing homelessness | NG214 | | |
| Mental wellbeing at work | NG212 | | |
| Odevixibat for treating progressive familial intrahepatic cholestasis | HST17 | | |
| Glaucoma: diagnosis and management | NG81 | | |
| Rehabilitation after traumatic injury | NG211 | | |
| Prostate cancer: diagnosis and management | NG131 | | |
| Colorectal cancer | NG151 | | |
| Pelvic floor dysfunction: prevention and non-surgical management | NG210 | | |
| Fever in under 5s: assessment and initial management | NG143 | | |
| Givosiran for treating acute hepatic porphyria | HST16 | | |
| Chronic kidney disease: assessment and management | NG203 | | |
| Acute heart failure: diagnosis and management | CG187 | | |
| Heart valve disease presenting in adults: investigation and management | NG208 | | |
| Inducing labour | NG207 | | |
| Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | NG206 | | |
| Looked-after children and young people | NG205 | | |
| Babies, children and young people's experience of healthcare | NG204 | | |
| Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s | NG202 | | |
| Antenatal care | NG201 | | |
| Bronchiolitis in children: diagnosis and management | NG9 | | |
| Atrial fibrillation: diagnosis and management | NG196 | | |
| Patient experience in adult NHS services: improving the experience of care for people using adult NHS services | CG138 | | |
| Shared decision making | NG197 | | |
| Autism spectrum disorder in adults: diagnosis and management | CG142 | | |
| Autism spectrum disorder in under 19s: support and management | CG170 | | |
| Heavy menstrual bleeding: assessment and management | NG88 | | |
| Postnatal care | NG194 | | |
| Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain | NG193 | | |
| Cannabis-based medicinal products | NG144 | | |
| Safeguarding adults in care homes | NG189 | | |
| Metreleptin for treating lipodystrophy | HST14 | | |
| Brain tumours (primary) and brain metastases in over 16s | NG99 | | |
| Pancreatitis | NG104 | | |
| Diabetes in pregnancy: management from preconception to the postnatal period | NG3 | | |
| Eating disorders: recognition and treatment | NG69 | | |
| Peripheral arterial disease: diagnosis and management | CG147 | | |
| Low back pain and sciatica in over 16s: assessment and management | NG59 | | |
| Acute coronary syndromes | NG185 | | |
| Volanesorsen for treating familial chylomicronaemia syndrome | HST13 | | |
| Rheumatoid arthritis in adults: management | NG100 | | |
| Behaviour change: digital and mobile health interventions | NG183 | | |
| Neuropathic pain in adults: pharmacological management in non-specialist settings | CG173 | | |
| Anaphylaxis: assessment and referral after emergency treatment | CG134 | | |
| Surgical site infections: prevention and treatment | NG125 | | |
| Perioperative care in adults | NG180 | | |
| Rehabilitation for adults with complex psychosis | NG181 | | |
| Generalised anxiety disorder and panic disorder in adults: management | CG113 | | |
| Intravenous fluid therapy in children and young people in hospital | NG29 | | |
| Joint replacement (primary): hip, knee and shoulder | NG157 | | |
| Abdominal aortic aneurysm: diagnosis and management | NG156 | | |
| Tinnitus: assessment and management | NG155 | | |
| Neonatal parenteral nutrition | NG154 | | |
| Antenatal and postnatal mental health: clinical management and service guidance | CG192 | | |
| Supporting adult carers | NG150 | | |
| Indoor air quality at home | NG149 | | |
| Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 | HST12 | | |
| Diverticular disease: diagnosis and management | NG147 | | |
| Workplace health: long-term sickness absence and capability to work | NG146 | | |
| Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management | CG184 | | |
| End of life care for adults: service delivery | NG142 | | |
| Diabetic foot problems: prevention and management | NG19 | | |
| Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations | HST11 | | |
| Gastro-oesophageal reflux disease in children and young people: diagnosis and management | NG1 | | |
| Familial hypercholesterolaemia: identification and management | CG71 | | |
| Attention deficit hyperactivity disorder: diagnosis and management | NG87 | | |
| Patisiran for treating hereditary transthyretin amyloidosis | HST10 | | |
| Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism | NG89 | | |
| Alcohol interventions in secondary and further education | NG135 | | |
| Chronic obstructive pulmonary disease in over 16s: diagnosis and management | NG115 | | |
| End of life care for infants, children and young people with life-limiting conditions: planning and management | NG61 | | |
| Motor neurone disease: assessment and management | NG42 | | |
| Long-acting reversible contraception | CG30 | | |
| Depression in children and young people: identification and management | NG134 | | |
| Urinary incontinence and pelvic organ prolapse in women: management | NG123 | | |
| Hyperparathyroidism (primary): diagnosis, assessment and initial management | NG132 | | |
| Inotersen for treating hereditary transthyretin amyloidosis | HST9 | | |
| Ulcerative colitis: management | NG130 | | |
| Crohn's disease: management | NG129 | | |
| Intrapartum care for women with existing medical conditions or obstetric complications and their babies | NG121 | | |
| Specialist neonatal respiratory care for babies born preterm | NG124 | | |
| Cerebral palsy in adults | NG119 | | |
| Renal and ureteric stones: assessment and management | NG118 | | |
| Post-traumatic stress disorder | NG116 | | |
| Myeloma: diagnosis and management | NG35 | | |
| Lyme disease | NG95 | | |
| Renal replacement therapy and conservative management | NG107 | | |
| Decision-making and mental capacity | NG108 | | |
| Preventing suicide in community and custodial settings | NG105 | | |
| Flu vaccination: increasing uptake | NG103 | | |
| Community pharmacies: promoting health and wellbeing | NG102 | | |
| Dementia: assessment, management and support for people living with dementia and their carers | NG97 | | |
| Cancer of the upper aerodigestive tract: assessment and management in people aged 16 or over | NG36 | | |
| Care and support of people growing older with learning disabilities | NG96 | | |